The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:

Policy Notices

• Reminder: FORMS-F Grant Application Forms & Instructions Must be Used for Due Dates On or After May 25, 2020- New Grant Application Instructions Now Available
  National Institutes of Health
  Agency for Healthcare Research and Quality

• NIH LATE APPLICATION POLICY Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)
  National Institutes of Health

• General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19
  National Institutes of Health

• Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19
  National Institutes of Health

General Notices

• Clarification of Research Strategy Structure for PAR-20-105 "Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed."
  Food and Drug Administration

• Notice of Change to the Application Due Date for RFA-FD-20-012 titled "Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) (U18) Clinical Trials Not Allowed"
  Food and Drug Administration

• The National Institutes of Health (NIH) Sexual & Gender Minority Research Office Request for Nominations for 2020 SGM Research Investigator Awards Program
  National Institutes of Health

• Request for Information (RFI): Biological Research Needs for High Spatial Resolution Imaging Supported by the Department of Energy and the National Institutes of Health
  National Institute of General Medical Sciences
  National Institute of Biomedical Imaging and Bioengineering

• Request for Information: Challenges and Opportunities in Understanding Cellular Senescence and Senolytics
  Office of Strategic Coordination (Common Fund)

Notice of Changes to Funding Opportunities

• Notice of NIEHS Participation in PAR-20-125 "Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional)"
  National Institute of Environmental Health Sciences

• Notice of Change to the Application Due Date and Award Budget for RFA-FD-20-020 titled Renewal - Investigation of impact of manufacturing difference and formulation variation on drug release for Levonorgestrel Intrauterine System (U01)
  Food and Drug Administration

• Notice of change to R&R Budget for RFA-FD-20-026 Cooperative Agreement for Data Collection on Antimicrobial Use in Dogs and Cats (U01) Clinical Trials Not Allowed
  Food and Drug Administration

• Notice of Change to the Application Due Date for RFA-FD-20-007 titled "Center for Collaborative Research on Complex Generics (U18) Clinical Trials Optional."
  Food and Drug Administration

• Notice of Change to the Application Due Date for PAR-19-190 titled "Advancing Post-Market Surveillance of High-Risk Facilities and Products through Signal detection, Data analysis, and the Review of the State of Quality (U01) Clinical Trial Optional."
  Food and Drug Administration

• Notice of Change to the Application Due Date for PAR-19-216 titled "Advancing Manufacturing Processing and Control Strategies for Drug Substances and Drug Products (U01)- Clinical Trial Optional."
  Food and Drug Administration

• Notice to extend the 2020 Application Due Date for PAR-20-091 "Revision Applications - FSMA Human Foods Preventive Controls Implementation Expansion Supplement to RFA-FD-18-001 (U18 Clinical Trials Not Allowed)"
  Food and Drug Administration

• Notice of NHGRI Participation in PAR-20-039, Support of Competitive Research (SCORE) Research Advancement Award (SC1 Clinical Trial Not Allowed)
  National Human Genome Research Institute

• Notice of NHGRI Participation in PAR-20-040, Support of Competitive Research (SCORE) Pilot Project Award (SC2 Clinical Trial Not Allowed)
  National Human Genome Research Institute

• Notice of NHGRI Participation in PAR-20-041, Support of Competitive Research (SCORE) Research Continuance Award (SC3 Clinical Trial Not Allowed)
  National Human Genome Research Institute

• Notice of Change in Key Dates for RFA-MH-20-400 "Effectiveness of Implementing Sustainable Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Mental Health Equity for Traditionally Underserved Populations (R01 CT Optional)"
  National Institute of Mental Health

• Notice of Change in Key Dates for RFA-MH-20-401 "Implementing and Sustaining Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Equity in Outcomes (R34 Clinical Trial Required)"
  National Institute of Mental Health

• Notice of Change to salary allowance for K00 awardees for NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Independent Clinical Trial Not Allowed)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research

• Notice of Change to Key Dates for PA-18-358 "NINDS Exploratory Neuroscience Research Grant (R21 - Clinical Trial Optional)"
  National Institute of Neurological Disorders and Stroke

Notices of Special Interest

• Notice of Special Interest: Digital Technology for Early Detection of Alzheimers Disease and Related Dementias
  National Institute on Aging

• Notice of Special Interest (NOSI): Advancing Head and Neck Cancer Early Detection Research (AHEAD)
  National Cancer Institute
  National Institute of Dental and Craniofacial Research

• Notice of Special Interest: Administrative Supplements to Support Resource Hubs to Promote Multi-Sectoral Rural Health Disparities Research
  National Institute on Minority Health and Health Disparities 

• Notice of Special Interest for HEAL Initiative: Request for Administrative Supplements to Existing Grants for Identification and Validation of New Pain and Opioid Use Disorder Targets within the Understudied Druggable Genome
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Neurological Disorders and Stroke

Funding Opportunities

• Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
  National Institutes of Health
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Human Genome Research Institute
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute on Minority Health and Health Disparities 
   
• Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
  National Cancer Institute
   
• Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33 Clinical Trial Required)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Cancer Institute
   
• Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones (R21/R33 Clinical Trial Required)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Cancer Institute
   
• Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed)
  National Cancer Institute
  
   
• In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Institute of Dental and Craniofacial Research
  Office of Research on Women's Health
   
• Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
  National Institute of Allergy and Infectious Diseases
  National Institute on Aging
  
   
• Artificial Intelligence and Technology Collaboratories for Aging Research Coordinating Center (AITCC) (R24 Clinical Trial Not Allowed)
  National Institute on Aging
  
   
• Engineering Immunity to HIV-1 Through Next Generation Vaccines (R61/R33 Clinical Trial Not Allowed)
  National Institute of Allergy and Infectious Diseases
  
   
• Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)
  National Institute of Allergy and Infectious Diseases
  
   
• Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R01 Clinical Trial Not Allowed)
• Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R21 Clinical Trial Not Allowed)
  National Institute of Dental and Craniofacial Research
  
   
• Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial Not Allowed)
  National Institute of Diabetes and Digestive and Kidney Diseases
   
• Exploring the use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making (U01) Clinical Trials Optional
  Food and Drug Administration
    
   
• Incorporating cost effectiveness & societal outcomes into FDA opioids model (U01) Clinical Trials Not Allowed
  (RFA-FD-20-031)
  Food and Drug Administration
   
• Postdoctoral Training in Pediatric Clinical Pharmacology (T32 Clinical Trial Not Allowed)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
   
• NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)
  National Human Genome Research Institute
   
• Limited Competition: Sickle Pan-African Research Consortium Clinical Coordinating Center (U24 Clinical Trial Optional)
  National Heart, Lung, and Blood Institute
   
• Limited Competition: Sickle Africa Data Coordinating Center (U24 Clinical Trial Optional)
  National Heart, Lung, and Blood Institute
   
• Sickle Pan-African Research Consortium Collaborative Sites (U01 Clinical Trial Optional)
  National Heart, Lung, and Blood Institute

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu